Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nabiximols for PTSD
NCT04592159Phase 3Withdrawn
- Sponsor
- Jazz Pharmaceuticals plc
- Start
- Feb 2021
- Primary completion
- Mar 2023
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of cannabis extract in post-traumatic stress disorder (PTSD), sponsored by Jazz Pharmaceuticals plc. Planned start Feb 2021; status: withdrawn.
02
Drugs
cannabis extract
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT04592159.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04592159.